Last update 08 May 2025

LCAR-M61D

Overview

Basic Info

Drug Type
Biological products
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [2]
Active Indication
Relapse multiple myeloma
Inactive Indication-
Originator Organization
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
Active Organization
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with LCAR-M61D
NCT06472479
/ Not yet recruitingNot ApplicableIIT
A Clinical Study to Evaluate the Safety, Tolerance and Efficacy of LCAR-M61S and LCAR-M61D Cell Preparations in Patients With Relapsed/Refractory Multiple Myeloma
100 Clinical Results associated with LCAR-M61D
Login to view more data
100 Translational Medicine associated with LCAR-M61D
Login to view more data
100 Patents (Medical) associated with LCAR-M61D
Login to view more data
100 Deals associated with LCAR-M61D
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free